Nektar Therapeutics (NKTR) Gross Margin (QoQ) (2010 - 2026)

Nektar Therapeutics (NKTR) Gross Margin (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Nektar Therapeutics 1.76 Bn 1.19 Bn 3.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -7,091.00
Dec 31, 2025 8,734.00
Sep 30, 2025 -8,734.00
Jun 30, 2025 16,501.00
Mar 31, 2025 -9,873.00
Dec 31, 2024 -2,063.00
Sep 30, 2024 213.00
Jun 30, 2024 400.00
Mar 31, 2024 -756.00
Dec 31, 2023 726.00
Sep 30, 2023 -1,737.00
Jun 30, 2023 -142.00
Mar 31, 2023 -439.00
Dec 31, 2022 -726.00
Sep 30, 2022 265.00
Jun 30, 2022 -228.00
Mar 31, 2022 323.00
Dec 31, 2021 -333.00
Sep 30, 2021 575.00
Jun 30, 2021 -272.00